VakSea

VakSea is a Maryland-based biotechnology company developing innovative oral vaccines for the aquaculture industry. The company's core technology leverages a proprietary insect-based biomanufacturing platform to produce recombinant protein vaccines at scale and low cost. These vaccines are designed to be incorporated directly into aquaculture feed, eliminating the need for individual injections and making mass vaccination of shrimp and fish feasible. VakSea's lead programs target high-impact viral diseases like White Spot Syndrome Virus (WSSV), which causes billions of dollars in annual losses to the global shrimp farming industry. By enhancing animal health and reducing reliance on antibiotics, VakSea supports the growth of sustainable and efficient aquaculture.